JP2012526052A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012526052A5 JP2012526052A5 JP2012508861A JP2012508861A JP2012526052A5 JP 2012526052 A5 JP2012526052 A5 JP 2012526052A5 JP 2012508861 A JP2012508861 A JP 2012508861A JP 2012508861 A JP2012508861 A JP 2012508861A JP 2012526052 A5 JP2012526052 A5 JP 2012526052A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- nephropathy
- disease
- pharmaceutical composition
- renal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17523509P | 2009-05-04 | 2009-05-04 | |
| US61/175,235 | 2009-05-04 | ||
| PCT/CA2010/000677 WO2010127440A1 (en) | 2009-05-04 | 2010-05-03 | Substituted aromatic compounds and pharmaceutical uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014229970A Division JP5815829B2 (ja) | 2009-05-04 | 2014-11-12 | 置換芳香族化合物およびその薬学的使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012526052A JP2012526052A (ja) | 2012-10-25 |
| JP2012526052A5 true JP2012526052A5 (https=) | 2013-06-20 |
Family
ID=43049874
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012508861A Ceased JP2012526052A (ja) | 2009-05-04 | 2010-05-03 | 置換芳香族化合物およびその薬学的使用 |
| JP2014229970A Expired - Fee Related JP5815829B2 (ja) | 2009-05-04 | 2014-11-12 | 置換芳香族化合物およびその薬学的使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014229970A Expired - Fee Related JP5815829B2 (ja) | 2009-05-04 | 2014-11-12 | 置換芳香族化合物およびその薬学的使用 |
Country Status (21)
| Country | Link |
|---|---|
| US (4) | US8927765B2 (https=) |
| EP (1) | EP2427416B1 (https=) |
| JP (2) | JP2012526052A (https=) |
| KR (2) | KR20120024696A (https=) |
| CN (1) | CN102438975B (https=) |
| AU (1) | AU2010244930B2 (https=) |
| BR (1) | BRPI1015124B8 (https=) |
| CA (1) | CA2761018C (https=) |
| DK (1) | DK2427416T3 (https=) |
| EA (1) | EA022445B1 (https=) |
| ES (1) | ES2575100T3 (https=) |
| HU (1) | HUE029126T2 (https=) |
| IL (1) | IL216006A (https=) |
| MX (1) | MX2011011757A (https=) |
| MY (1) | MY156780A (https=) |
| NZ (1) | NZ595978A (https=) |
| PL (1) | PL2427416T3 (https=) |
| PT (1) | PT2427416E (https=) |
| SG (1) | SG175855A1 (https=) |
| TW (1) | TWI485134B (https=) |
| WO (1) | WO2010127440A1 (https=) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2011011756A (es) * | 2009-05-04 | 2012-01-25 | Prometic Biosciences Inc | Sales de acido 3-pentilfenilacetico y usos farmaceuticos. |
| PT2427416E (pt) | 2009-05-04 | 2016-06-15 | Prometic Pharma Smt Ltd | Compostos aromáticos substituídos e seus usos farmacêuticos |
| AT509045B1 (de) * | 2010-01-29 | 2011-06-15 | Planta Naturstoffe Vertriebsges M B H | Verbindungen zur behandlung von asthma bronchiale |
| MX365807B (es) * | 2010-10-27 | 2019-06-14 | Prometic Pharma Smt Ltd | Compuestos y composiciones para el tratamiento del cáncer. |
| CA2816094A1 (en) * | 2010-10-27 | 2012-07-26 | Prometic Biosciences Inc. | Compounds and pharmaceutical compositions for uses in diabetes |
| TWI742541B (zh) | 2013-03-15 | 2021-10-11 | 英商邊緣生物科技有限公司 | 用於治療肺纖維化、肝纖維化、皮膚纖維化及心臟纖維化之經取代之芳族化合物 |
| TWI689490B (zh) | 2013-03-15 | 2020-04-01 | 英商邊緣生物科技有限公司 | 用於治療纖維化之經取代之芳族化合物及相關方法 |
| CA2930584A1 (en) | 2013-11-15 | 2015-05-21 | The Wistar Institute Of Anatomy And Biology | Ebna1 inhibitors and their method of use |
| GB201416017D0 (en) * | 2014-09-10 | 2014-10-22 | New Royal Holloway & Bedford | An Anticonvulsant Compound |
| ES2785317T3 (es) * | 2014-10-10 | 2020-10-06 | Liminal Biosciences Ltd | Compuestos aromáticos sustituidos y composiciones farmacéuticas para la prevención y el tratamiento de la osteoporosis |
| KR20170072352A (ko) * | 2014-11-12 | 2017-06-26 | 프로메틱 파마 에스엠티 리미티드 | 조직 자가-회복 및 재생을 위한 치환된 방향족 화합물 및 약제학적 조성물 |
| AU2016262572B2 (en) | 2015-05-14 | 2020-04-30 | The Wistar Institute Of Anatomy And Biology | EBNA1 inhibitors and methods using same |
| EP3793546B1 (en) | 2018-05-17 | 2025-11-19 | The Wistar Institute | Ebna1 inhibitor crystalline forms, and methods of preparing and using same |
| CN108997202A (zh) * | 2018-07-10 | 2018-12-14 | 湖南华腾制药有限公司 | 一种（5-三氟甲基-吡啶-2-基）-乙酸盐的制备方法 |
| MA53188A1 (fr) | 2018-10-11 | 2021-12-31 | Basf As | Composés aromatiques et leurs utilisations pharmaceutiques |
| WO2020113340A1 (en) * | 2018-12-05 | 2020-06-11 | Liminal Biosciences Limited | Use of sodium 2-(3-pentylphenyl)acetate in the treatment of alström syndrome |
| EP4051659B1 (en) * | 2019-10-31 | 2026-01-28 | Assia Chemical Industries Ltd. | Solid state forms of fezagepras and process for preparation thereof |
| CN115974773B (zh) * | 2022-12-30 | 2024-07-02 | 广东省科学院生物与医学工程研究所 | 甘蔗内生真菌所产的化合物及其在抑菌和抗氧化中的应用 |
| WO2024217515A1 (zh) * | 2023-04-19 | 2024-10-24 | 上海复宏汉霖生物技术股份有限公司 | 一种杂环取代的芳香化合物、其制备方法及用途 |
Family Cites Families (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2489348A (en) * | 1947-01-15 | 1949-11-29 | Hoffmann La Roche | Production of arylacetic acids and amides |
| US2618645A (en) * | 1948-11-12 | 1952-11-18 | Bowles Albert Frank | Organic mercurials |
| GB971700A (en) * | 1961-02-02 | 1964-09-30 | Boots Pure Drug Co Ltd | Anti-Inflammatory Agents |
| US4021478A (en) * | 1972-07-13 | 1977-05-03 | The Upjohn Company | Preparation of carboxylic acids from glycidonitriles with ionic lewis acids |
| GB1465219A (en) * | 1975-02-25 | 1977-02-23 | Juste Sa | Process for the preparation of a phenyl alkonoic acid and its salts |
| JPS52107837A (en) * | 1976-03-05 | 1977-09-09 | Ricoh Co Ltd | Wet type electrostatic development material |
| NL7709681A (nl) * | 1976-09-08 | 1978-03-10 | Sandoz Ag | Werkwijzen voor het bereiden en toepassen van fenylazijnzuurderivaten. |
| US4264582A (en) * | 1978-07-31 | 1981-04-28 | The Procter & Gamble Company | Isobutylphenylacetate anti-inflammatory composition |
| JPS5656899A (en) * | 1979-10-17 | 1981-05-19 | Pilot Pen Co Ltd:The | Recording material |
| FR2497524B1 (https=) | 1981-01-07 | 1985-12-13 | Rhone Poulenc Spec Chim | |
| JPS5855469A (ja) * | 1981-09-25 | 1983-04-01 | Sumitomo Chem Co Ltd | イソシアヌル酸誘導体、その製造方法およびこれを有効成分とする有機物質用安定剤 |
| US4482439A (en) * | 1984-04-05 | 1984-11-13 | Reilly Tar & Chemical Corp. | Electrochemical oxidation of pyridine bases |
| EP0268907A3 (en) | 1986-11-19 | 1990-03-21 | Carl Richard Thornfeldt | Treatment of disease conditions relating to hyperactive organelles |
| JPS63236519A (ja) * | 1987-03-24 | 1988-10-03 | Ube Ind Ltd | 有害廃ガスの処理方法 |
| CA2004028C (en) * | 1988-12-08 | 1998-09-22 | Motoki Torizuka | Condensed benzene derivative |
| IE70430B1 (en) * | 1990-02-13 | 1996-11-27 | Lonza Ag | Microbiological oxidation of methyl groups in heterocyclic compounds |
| US5605930A (en) * | 1991-10-21 | 1997-02-25 | The United States Of America As Represented By The Department Of Health And Human Services | Compositions and methods for treating and preventing pathologies including cancer |
| GB9200689D0 (en) * | 1992-01-14 | 1992-03-11 | Rhone Poulenc Agriculture | New compositions of matter |
| US5366996A (en) | 1992-12-07 | 1994-11-22 | Elford Howard L | Method of treating hemoglobinopathies |
| IT1270846B (it) | 1993-05-10 | 1997-05-13 | Alfa Wassermann Spa | Uso di sulodexide e delle specialita' medicinali che lo contengono nel trattamento della nefropatia diabetica. |
| US20060074063A1 (en) | 1995-12-29 | 2006-04-06 | Fernandez-Pol Jose A | Pharmacological agent and method of treatment |
| US7030146B2 (en) | 1996-09-10 | 2006-04-18 | University Of South Carolina | Methods for treating diabetic neuropathy |
| JPH11343283A (ja) * | 1998-05-29 | 1999-12-14 | Koei Chem Co Ltd | ピリジンカルボン酸の製造法 |
| EP1200460A1 (en) * | 1999-07-15 | 2002-05-02 | Eli Lilly And Company | Pseudomycin n-acyl side-chain analogs |
| WO2001074487A1 (en) * | 2000-04-04 | 2001-10-11 | Daicel Chemical Industries, Ltd. | Method of separating imide compound |
| ITMI20012434A1 (it) * | 2001-11-20 | 2003-05-20 | Dompe Spa | Acidi 2-aril-propionici e composizioni farmaceutiche che li contengono |
| FR2849849B1 (fr) * | 2003-01-13 | 2006-08-04 | Merck Sante Sas | Nouveaux acides carboxyliques et derives pour le traitement et la prevention du diabete et des dyslipemies |
| BRPI0616463A2 (pt) * | 2005-09-29 | 2011-06-21 | Merck & Co Inc | composto, composição farmacêutica, e, uso de um composto |
| US20100010002A1 (en) | 2006-09-01 | 2010-01-14 | Piramal Life Sciences Limited | Anticancer use of caffeic acid and its derivatives |
| ES2400163T3 (es) * | 2006-09-08 | 2013-04-08 | Actelion Pharmaceuticals Ltd. | Derivados de piridil-3-ilo como agentes de inmunomodulación |
| US8598208B2 (en) * | 2007-08-17 | 2013-12-03 | Actelion Pharmaceuticals Ltd. | Pyridine derivatives as S1P1/EDG1 receptor modulators |
| ZA200801666B (en) * | 2007-09-29 | 2009-01-28 | Merck & Co Inc | Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators |
| WO2009055932A1 (en) | 2007-11-02 | 2009-05-07 | Prometic Biosciences Inc. | Substituted phenylpropionic acids as stimulators of hematopoiesis and erythropoiesis |
| CN101878028A (zh) | 2007-11-02 | 2010-11-03 | 普罗米蒂克生物科学公司 | 作为肾保护剂的中链长度脂肪酸和甘油酯 |
| NZ586249A (en) | 2007-12-19 | 2012-05-25 | Prometic Biosciences Inc | A combination of medium-chain length fatty acids, salts or triglycerides, gemcitabine, and optionally erlotinib, for the treatment of pancreatic cancer |
| PT2427416E (pt) | 2009-05-04 | 2016-06-15 | Prometic Pharma Smt Ltd | Compostos aromáticos substituídos e seus usos farmacêuticos |
| MX2011011756A (es) * | 2009-05-04 | 2012-01-25 | Prometic Biosciences Inc | Sales de acido 3-pentilfenilacetico y usos farmaceuticos. |
-
2010
- 2010-05-03 PT PT107719338T patent/PT2427416E/pt unknown
- 2010-05-03 CA CA2761018A patent/CA2761018C/en active Active
- 2010-05-03 TW TW099114044A patent/TWI485134B/zh not_active IP Right Cessation
- 2010-05-03 HU HUE10771933A patent/HUE029126T2/en unknown
- 2010-05-03 PL PL10771933.8T patent/PL2427416T3/pl unknown
- 2010-05-03 KR KR1020117028778A patent/KR20120024696A/ko not_active Ceased
- 2010-05-03 KR KR1020187001772A patent/KR101923354B1/ko not_active Expired - Fee Related
- 2010-05-03 EA EA201171350A patent/EA022445B1/ru not_active IP Right Cessation
- 2010-05-03 WO PCT/CA2010/000677 patent/WO2010127440A1/en not_active Ceased
- 2010-05-03 MY MYPI2011004980A patent/MY156780A/en unknown
- 2010-05-03 CN CN201080023204.7A patent/CN102438975B/zh not_active Expired - Fee Related
- 2010-05-03 DK DK10771933.8T patent/DK2427416T3/en active
- 2010-05-03 BR BRPI1015124A patent/BRPI1015124B8/pt not_active IP Right Cessation
- 2010-05-03 NZ NZ595978A patent/NZ595978A/xx not_active IP Right Cessation
- 2010-05-03 AU AU2010244930A patent/AU2010244930B2/en not_active Ceased
- 2010-05-03 SG SG2011080496A patent/SG175855A1/en unknown
- 2010-05-03 ES ES10771933.8T patent/ES2575100T3/es active Active
- 2010-05-03 EP EP10771933.8A patent/EP2427416B1/en active Active
- 2010-05-03 JP JP2012508861A patent/JP2012526052A/ja not_active Ceased
- 2010-05-03 MX MX2011011757A patent/MX2011011757A/es active IP Right Grant
-
2011
- 2011-10-27 IL IL216006A patent/IL216006A/en active IP Right Grant
- 2011-11-04 US US13/289,592 patent/US8927765B2/en active Active
-
2014
- 2014-11-12 JP JP2014229970A patent/JP5815829B2/ja not_active Expired - Fee Related
- 2014-12-08 US US14/563,523 patent/US9938221B2/en active Active
-
2018
- 2018-02-07 US US15/890,927 patent/US10815183B2/en not_active Expired - Fee Related
-
2020
- 2020-09-23 US US17/029,197 patent/US20210002202A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012526052A5 (https=) | ||
| JP2015061852A5 (https=) | ||
| Ismaili et al. | Multitarget compounds bearing tacrine-and donepezil-like structural and functional motifs for the potential treatment of Alzheimer's disease | |
| CN102438975B (zh) | 取代的芳香化合物及其药物用途 | |
| JP2016531861A5 (https=) | ||
| SI2820009T1 (en) | Serine / Threonine kinase inhibitors | |
| BR112015017338A2 (pt) | anticorpos anti-il-17a e seu uso no tratamento de transtornos autoimunes e inflamatórios | |
| WO2013101974A8 (en) | COMPOUNDS FOR TREATING SPINAL AMYOTROPHY | |
| CR20170078A (es) | Formulaciones en compromido de la (4-trifluorometilfenil)amida del acido (z)-2-ciano-3-hidroxibutil-2-enoico con estabilidad mejorada | |
| JP2012514126A5 (https=) | ||
| JP2011505499A5 (https=) | ||
| MA33447B1 (fr) | Nouveau composé utilisé pour traiter les maladies dégénératives et inflammatoires | |
| JP2015504073A5 (https=) | ||
| JP2020502047A5 (https=) | ||
| CL2014003167A1 (es) | Molécula de unión que se une específicamente a inteleuquina 6 (il-6); composición farmacéutica que la comprende; ácido nucleico; vector; célula huésped; y uso para tratar enfermedad o trastorno asociado a il-6. | |
| EA201592308A1 (ru) | N-(4-гидрокси-4-метилциклогексил)-4-фенилбензолсульфонамиды и n-(4-гидрокси-4-метилциклогексил)-4-(2-пиридил)бензолсульфонамиды и их терапевтическое применение | |
| JP2009501202A5 (https=) | ||
| MA38295A1 (fr) | Dérivé d'azole et de benzène | |
| EA201070783A1 (ru) | 1,2,4-оксадизольные соединения для лечения аутоиммунных заболеваний | |
| MX347157B (es) | Derivados de acido 3-heteroaroilamino-propionico sustituidos y su uso como sustancias farmaceuticas. | |
| JP2017505809A5 (https=) | ||
| Tang et al. | Fluorofenidone protects against renal fibrosis by inhibiting STAT3 tyrosine phosphorylation | |
| WO2009148566A3 (en) | Development of a c-reactive protein mutant with improved therapeutic benefit in immune thrombocytopenia and lupus nephritis | |
| JP2013507377A5 (https=) | ||
| JP2013528625A5 (https=) |